| Literature DB >> 31392563 |
Narjes Ahmadian1, Kirsten van Baarsen2, Martine van Zandvoort3, Pierre A Robe4.
Abstract
The cerebellar cognitive affective syndrome (CCAS) was first described by Schmahmann and Sherman in 1998. Despite their clear depiction of the syndrome, it is our experience that the CCAS has not yet found solid ground as a disease entity in routine clinical practice. This made us question the dimension of the CCAS in cerebellar patients. We performed a systematic review of the literature according to the PRISMA guidelines, in order to answer the question whether patients with acquired isolated cerebellar lesions perform significantly worse on neuropsychological testing compared to healthy controls. Studies were selected based on the predefined eligibility criteria and quality assessment. The systematic search resulted in ten studies, mainly observational cohorts consecutively including adult patients with isolated cerebellar lesions. Patients were compared to healthy controls, and neuropsychological investigation was done within one year of diagnosis. Meta-analysis of the twelve tests that were done in two or more studies showed that cerebellar patients perform significantly worse on Phonemic Fluency, Semantic Fluency, Stroop Test (naming, reading and interference), Block Design test and WMS-R visual memory. Cerebellar patients have significant and relevant deficits in the visuospatial, language and executive function domain. This meta-analysis therefore emphasizes the importance of the cerebellar cognitive affective syndrome as described by Schmahmann and Sherman.Entities:
Keywords: Affection; CCAS; Cerebellar cognitive affective syndrome; Cerebellum; Executive function; Language; Neuropsychological tests; Visuospatial
Mesh:
Year: 2019 PMID: 31392563 PMCID: PMC6761084 DOI: 10.1007/s12311-019-01060-2
Source DB: PubMed Journal: Cerebellum ISSN: 1473-4222 Impact factor: 3.847
Search syntax for Embase, Pubmed and Cochrane databases
| Anatomical location | AND | Neuropsychological functions | AND | Pathology |
|---|---|---|---|---|
| cerebel* [ti] | cognit* [tiab] OR language [tiab] OR speech [tiab] OR behaviour [tiab] OR behavior [tiab] OR affective [tiab] OR non motor [tiab] OR non-motor [tiab] OR CCAS [tiab] OR memory [tiab] OR verbal [tiab] OR attention [tiab] OR spatial [tiab] OR learn* [tiab] OR metalinguistic [tiab] OR visuospatial [tiab] OR visualization [tiab] OR planning [tiab] OR executive [tiab] OR emotional [tiab] | hemorrhage [tiab] OR haemorrhage [tiab] OR tumor [tiab] OR tumour [tiab] OR stroke [tiab] OR infarct* [tiab] OR bleed* [tiab] OR lesion* [tiab] OR dentate nucleus [tiab] OR nuclei [tiab] OR SCA [tiab] OR PICA [tiab] OR AICA [tiab] OR ataxia* [tiab] OR disorder [tiab] OR deficit* [tiab] OR impairment* [tiab] OR disease [tiab] OR dysfunction* [tiab] OR degeneration [tiab] OR disturbance* [tiab] OR pathology [tiab] OR damage [tiab] OR abnormal* [tiab] OR atroph* [tiab] |
Quality assessment. Studies were accredited a maximum of 2 points per criterium: 2 when criterium was met, 1 when unclear and 0 when criterium was definitely not met
| Authors | Consecutive pt enrollment | > 20 pts enrolled | > 75% underwent NPT | Use of control group | Time interval to assessments < 1 year | Total score |
|---|---|---|---|---|---|---|
| Frank, B (2010) | 2 | 2 | 2 | 2 | 2 | 10 |
| Frank, B (2013) | 2 | 2 | 2 | 2 | 2 | 10 |
| Hokkanen, L. S (2006) | 2 | 2 | 2 | 2 | 2 | 10 |
| Karaci, R (2008) | 2 | 2 | 1 | 2 | 2 | 9 |
| Exner, C (2004) | 2 | 0 | 2 | 2 | 2 | 8 |
| Gottwald, B (2004) | 1 | 2 | 2 | 2 | 1 | 8 |
| Harrington, D.L (2004) | 2 | 2 | 2 | 2 | 0 | 8 |
| Mak, M (2016) | 1 | 2 | 2 | 2 | 1 | 8 |
| Neau, J.P (2000) | 2 | 0 | 2 | 2 | 2 | 8 |
| Bolcekova (2017) | 0 | 2 | 2 | 2 | 2 | 8 |
Fig. 1Flow chart of study selection
Fig. 2Forest plots of meta-analysis (as per 01 July 2019)
Box 1Description of neuropsychological tests